Skip to main content
Article
Radioimmunotherapy-Augmented Nonmyeloablative Allogeneic Transplantation Improves Outcomes for Refractory Indolent B-Cell Non-Hodgkin Lymphoma: Results of an Adjusted Cohort Analysis
Biology of Blood and Marrow Transplantation (2014)
  • Ryan D. Cassaday, Fred Hutchinson Cancer Research Center
  • Barry E. Storer, Fred Hutchinson Cancer Research Center
  • Mohamed L. Sorror, Fred Hutchinson Cancer Research Center
  • Brenda M. Sandmaier, Fred Hutchinson Cancer Research Center
  • Katherine A. Guthrie, Fred Hutchinson Cancer Research Center
  • Lacey M. Hedin, Fred Hutchinson Cancer Research Center
  • Jennifer E. Roden, Fred Hutchinson Cancer Research Center
  • Joseph G. Rajendran, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Rainer F. Storb, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
Publication Date
January 2, 2014
DOI
10.1016/j.bbmt.2013.12.087
Citation Information
Ryan D. Cassaday, Barry E. Storer, Mohamed L. Sorror, Brenda M. Sandmaier, et al.. "Radioimmunotherapy-Augmented Nonmyeloablative Allogeneic Transplantation Improves Outcomes for Refractory Indolent B-Cell Non-Hodgkin Lymphoma: Results of an Adjusted Cohort Analysis" Biology of Blood and Marrow Transplantation Vol. 20 Iss. 2 (2014)
Available at: http://works.bepress.com/john-pagel/111/